Conexeu Sciences Inc. Reports Unregistered Issuance of Shares and Warrants

What Happened Conexeu Sciences Inc. filed an 8‑K on September 10, 2026 (Item 3.02) disclosing that it issued an aggregate of 1,448,368 unregistered shares of common stock and 202,500 unregistered common stock purchase warrants pursuant to various agreements and the exercise of outstanding warrants. The aggregate issuance exceeded 5% of the Company’s issued and outstanding common stock since its last periodic report, triggering the required SEC disclosure.

Key Details

• Issued 1,448,368 unregistered shares of common stock (aggregate figure reported).
• Issued 202,500 unregistered common stock purchase warrants.
• Filing date: September 10, 2026 (8‑K, Item 3.02).
• Disclosure was required because the aggregate issuances exceeded 5% of outstanding common stock since the last periodic report.

Why It Matters This filing informs investors that the company increased its outstanding equity by a meaningful amount (over 5%), which directly changes share count and ownership percentages. The issued warrants, if exercised, could further increase the number of shares outstanding. The 8‑K does not provide detailed financial terms (e.g., cash proceeds or exercise prices) in the item disclosure, so investors seeking impact on valuation or dilution percentages should monitor future filings or company disclosures for those specifics.